Assistant Professor, Internal Medicine 
Division of Hematology & Oncology
Academic office:
987680 Nebraska Medical Center
Lied Transplant Center, Room 8716
Omaha, NE 681980-7680
Primary Location:
Peggy D. Cowdery Patient Care Center
Lied Transplant Center
987835 Nebraska Medical Center
Omaha, NE 68198-7835
Ph. 402-559-3848 Fax. 402-559-6520
Secondary Location:
Cancer Center at Village Pointe
111 North 175th Street
Omaha, NE 68118
Ph. 402-596-3100
Education:
Michigan State University, Fellow [2009]
University of Pittsburgh – Mercy Hospital, Resident [2006]
Lake Erie College of Osteopathic Medicine [2003]
Duquesne University, MS [1999]
Allegheny College, BS [1992]
Hospital Appointments:
The Nebraska Medical Center University Hospital
UNMC – Bellevue
Interests:
Main practice focus is clinical and basic science research for multiple myeloma. Secondary foci include Amyloidosis, Acute/Chronic Myelogenous Leukemias as well as MDS, Myeloproliferative Disorders, Aplastic Anemia, Benign Hematology; Autologous and Allogeneic Hematopoietic Cell Transplantation
Biographical Sketch:
Dr. Faber is an assistant professor of internal medicine in the Oncology/Hematology Division at UNMC and an NCCN panel member for multiple myeloma. He currently is a principal investigator for all phases of clinical trials, while collaborating with cooperative groups such as ECOG, CALGB and BMT CTN, as well as industry-sponsored clinical trials. His special interest in clinical trials involves early, novel therapies for relapsed / refractory multiple myeloma. Dr. Faber serves on national advisory boards and speaker bureaus, as well as serving as a manuscript reviewer for national publications. He is an active member of ASH, ASCO and ASBMT. Dr. Faber has been appointed to the UNMC Hematology/Oncology Fellowship Committee and is the Co Director of UNMC’s M1/M2 Oncology/Hematology Core Course.
Select Publications:
Faber Jr EA, Vose JM.. Diagnosis and Treatment of Non-Hodgkin’s Lymphoma of Adults. Neoplastic Diseases of the Blood. Wiernik PH, Goldman JM, Dutcher JP, Kyle RA (Eds), Springer Science+Business Media, Inc., Fifth Edition. In press, 2011
Raje NS, Hohl RJ, Faber Jr EA, et al. Phase 1 study of LY2127399, a human anti-BAFF antibody, and bortezomib in patients with previously-treated multiple myeloma. Abstract #74188, ASCO Annual Meeting. Accepted for presentation, June 2011
Faber Jr EA, Vose JM. The Role of Hematopoietic Cell Transplantation in Follicular Lymphoma. J Natl Compr Canc Netw. 2010 Mar;8(3):337-45. PMID: 20202463
Martin K, Reade C, Faber Jr EA. "Acute Severe Hypophosphatemia in IgG kappa Multiple Myeloma Treated with Lenalidomide". American College of Physicians, Nebraska Chapter Meeting. 2009
Faber Jr EA, KA Schwartz, S Nagpal, et al. Hypercoagulation in Malignancy: Localized by Thromboelastography [TEG] to the Humoral Phase of Coagulation. CSCR/MWAFMR Chicago, IL 2009, Poster Number 75 and ISTH, Boston MA, Poster PP-WE-495. 2009
S Nagpal, KA Schwartz, Faber Jr EA, et al. The Role of Thromboelastography (TEG) in Predicting Thrombosis in Cancer Patients. Blood (ASH Annual Meeting Abstracts) 112: Abstract 5352, 2008
Faber Jr EA, Alirah S, Tamkus D. Case Report: DCIS and BRCA, the Value of Sentinel Lymph Node Biopsy. ACP Scientific Meeting. September 2007
Faber Jr EA, Geyer S. Vena Cava Thrombosis and Fatal Pulmonary Death. Lab Medicine 33:553-555, 2002
